Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs

Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs

Metabolic dysfunction-associated steatotic liver disease (MASLD) is considered a “multisystem” disease that simultaneously suffers from metabolic diseases and hepatic steatosis. Some may develop into liver fibrosis, cirrhosis, and even hepatocellular carcinoma. Given the close connection between met...

Full description

Bibliographic Details
Main Authors: Baoqiang Zhu, Yuankui Wei, Mingming Zhang, Shiyu Yang, Rongsheng Tong, Wenyuan Li, Enwu Long
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Pharmacology
Subjects:
metabolic disease
ferroptosis
therapeutic drugs
metabolic dysfunction-associated steatotic liver disease (MASLD)
mechanism
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1286449/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1286449/full

Similar Items